Generics 4

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Neomycin sulfate manufacturers

4 products found

Filters

Filters

Filters , active

Country of origin : Bangladesh

Clear all

4 products found

neomycin sulfate + nystatin + clobetasol propionate

Ointment 0.5 % + 100000 IU + 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

neomycin sulfate + nystatin + clobetasol propionate

Cream 0.5 % + 100000 IU + 0.05 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #21340
The company is a leading conglomerate with a diverse range of business operations across multiple industries. The website is structured to provide detailed financial information through sections like “Annual Report,” “Quarterly Report,” and “Price Sensitive Information,” which include links to various reports from recent years and updates on financial performance, such as notices about bond issuances. The company operates in several key sectors, including textiles, pharmaceuticals, personal protective equipment (PPE), ceramics, information and communication technology (ICT), real estate and trading, media, financial services, energy, and travel and tourism. As the largest entity within its group, the company plays a significant role in driving economic activities and growth across these industries, reflecting its strong market presence and commitment to diversified business interests.

Manufacturer usually replies in 8 days

clobetasol propionate + neomycin sulfate + nystatin

Cream 0.05% w/w + 0.5% w/w +100,000 units/gram

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Bangladesh
GMP approvals
WHO
Manufacturer #16099
This pharmaceutical company, established in 2009 and acquired by other company. in 2020, boasts state-of-the-art manufacturing facilities adhering to international standards like WHO-GMP, US-FDA, and Australian-TGA guidelines. They operate within the EU, North America, and several countries in Asia and Africa. Their product portfolio includes over 100 registered medications spanning a range of therapy areas including oncology, virology, and hematology. They offer various dosage forms, with a particular focus on generic medications. The company holds multiple product patents and is committed to green initiatives.

Manufacturer usually replies in 6 days

Want to see all 4 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Neomycin Sulfate Manufacturers

Neomycin Sulfate belongs to the class of antibiotics and it is used to reduce the risk of infection during surgery of the bowel. Neomycin Sulfate is also used to reduce the symptoms of hepatic coma. Neomycin Sulfate has been shown to be an effective adjunctive therapy in a hepatic coma by reduction of the ammonia-forming bacteria in the intestinal tract. Neomycin sulfate is also combined with oral erythromycin or metronidazole and given in addition to intravenous prophylaxis. Neomycin Sulfate is Marketed with the brand name Neo-Fradin, Neo-Tab, Neosporin, Mycifradin. Neomycin Sulfate is advised as a prescription product and generic prescription product. Neomycin Sulfate is available in dosage form of Tablet and Solution which are available in dosage strengths of 500 mg /1, 87.5 mg/5mL. Neomycin Sulfate Tablets, USP, for oral administration, contain neomycin sulfate which is an antibiotic obtained from the metabolic products of the actinomycete Streptomyces radiate. Neomycin Sulfate Tablets are taken orally in doses of 4-12 grams of Neomycin Sulfate tablets per day (eight to 24 tablets) in divided doses. Treatment should be continued over a period of five to six days, during which time protein should be returned incrementally to the diet. Neomycin Sulfate Tablets, USP, 500 mg (equivalent to 350 mg of neomycin Sulfate base per tablet) are available as round, off-white, unscored tablets, debossed “500” and “PT”. Neomycin oral solution is available as a clear orange solution available in bottles. The usual recommended adult dose of neomycin sulfate for Hepatic Encephalopathy and Hepatic Coma is 4 to 12 grams orally per day which is taken in divided doses for a duration of 5 to 6 days. Before starting the treatment, protein should be withdrawn from the diet and diuretic agents should be avoided. The usual pediatric dose for bowel preparation is 15 mg/kg orally given which is divided into 3 doses and administered over 10 hours approximately before the operation and after the mechanical bowel preparation. Neomycin Sulfate Oral solution formulations should be stored at 20° C to 25° C (68° F - 77° F).

Wholesale Price of Neomycin Sulfate

The lowest available price for neomycin sulfate 500 mg is around $7.06 for a supply of 6 tablets.

Neomycin Sulfate - Mechanism of action

Neomycin Sulfate is active against both gram-positive and gram-negative organisms, including the major E. coli species resident in the colon as well as the enteropathogenic forms of E. coli. Neomycin Sulfate bactericidal in action. Like other aminoglycosides, neomycin Sulfate inhibits bacterial protein synthesis through irreversible binding to the 30 S ribosomal subunit of susceptible bacteria. Neomycin Sulfate is actively transported into the bacterial cell where it binds to receptors present on the 30 S ribosomal subunit. The bacterial translation is normally initiated by the mRNA binding to the 30S ribosomal subunit and subsequent binding with the 50S subunit for elongation. Neomycin Sulfate is poorly absorbed from the gastrointestinal tract. Gastrointestinal absorption of the drug may be increased if the inflammatory or ulcerative gastrointestinal disease is present.

Finding Neomycin Sulfate Manufacturers and Suppliers

To find an honest partner in our business is one of the big tests and to defeat that test and to make one’s work/life easy in finding the honest manufacturer and supplier of neomycin sulfate one can visit the Pipelinepharma website which helps the buyer in finding the dependable manufacturers and suppliers of neomycin sulfate. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products, quickly connects proprietor with the consumers for the business development. The buyer can filter the product names in user familiar and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible